Ozempic stock price touched an intraday high of $126

Ozempic stock price touched an intraday high of $126.50, a two-month peak, before easing back to $ Stanley cited the lack of momentum in US prescriptions as the reason for its cautious outlook on the firm’s short-term growth profile, which led to the downgrade. What's less visiblebut no less importantis the political backdrop. Both the Trump and Biden administrations have taken swings at Novo over its US pricing, with Trump even sending direct letters to drugmakers. Last year, Novo's former CEO was grilled by Congress as Ozempic became the poster child for the US-vs-world drug cost divide. Officially, Novo says this new pricing has nothing to do with Washington. Unofficially? The timing couldn't be more convenient. Whether it's a PR play, a volume game, or a way to undercut compounders eating into market share, one thing's clear: Novo's playing a different hand in the GLP-1 war. Ozempic stock price is hovering near a key breakout zone around $125.